FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Keytruda is targeted to specific cancers with specific DNA that can arise in multiple sites

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.